James W. Mayer, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: Most physicians should and do believe the articles published in this journal rather than patient anecdotes, lay press stories on science, and hearsay within the medical community.
I attended a conference on the eosinophilia-myalgia syndrome in Los Alamos, New Mexico on 12 and 13 June 1990. At that conference, the Mayo Clinic was well represented, and clearly proposed that there was an abnormal "peak" in commercially produced L-tryptophan taken by patients. I was surprised to read a report by investigators from the Mayo Clinic (1) in the 15 July issue that "no organic contaminants were identified in
Mayer JW. Clarification of Contaminants in L-Tryptophan. Ann Intern Med. 1990;113:721–722. doi: https://doi.org/10.7326/0003-4819-113-9-721
Download citation file:
Published: Ann Intern Med. 1990;113(9):721-722.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use